Fig. 7.

Data describing the washout of ¹²⁵I-labeled albumin from the in situ gastrocnemius muscle of LZR and OZR under the conditions of the present study. Data are presented as means ± SE for LZR (n = 10) under control conditions and OZR under control conditions (total n = 28) and following intravenous treatment with the adrenoreceptor antagonist phentolamine (P; n = 10), the antioxidant TEMPOL (T; n = 9), the PGH₂/TxA₂ receptor blocker SQ-29548 (SQ; n = 9), or for combinations of these agents (n = 8–10 for each).